Effects of low‐dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin‐E2 do not depend on Helicobacter pylori infection - VENERITO, M.; TREIBER, G.; WEX, T.; KUESTER, D.; ROESSNER, A.; DI MARIO, F.; MALFERTHEINER, P. (Alimentary pharmacology & therapeutics, 2006)
Keywords: Adult; Anti-Bacterial Agents - therapeutic use; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Aspirin - administration & dosage; Aspirin - adverse effects; Biological and medical sciences; Case-Control Studies; Cyclooxygenase 1 - analysis; Cyclooxygenase 1 - metabolism; Cyclooxygenase 2 - analysis; Cyclooxygenase 2 - metabolism; Digestive system; Dinoprostone - analysis; Dinoprostone - metabolism; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa - drug effects; Gastric Mucosa - metabolism; Gastric Mucosa - pathology; Gastroenterology. Liver. Pancreas. Abdomen; Helicobacter Infections - drug therapy; Helicobacter Infections - metabolism; Helicobacter Infections - pathology; Helicobacter pylori; Humans; Immunohistochemistry - methods; Male; Medical sciences; Pharmacology. Drug treatments; Prostaglandin-Endoperoxide Synthases - analysis; Prostaglandin-Endoperoxide Synthases - metabolism; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Stomach; Prostaglandin-endoperoxide synthase; Spirillales; Digestive system; Enzyme; Arachidonic acid derivatives; Low dose; Mucosa; Enzyme inhibitor; Spirillaceae; Prostaglandin E2; Acetylsalicylic acid; Antiplatelet agent; Infection; Non steroidal antiinflammatory agent; Analgesic; Helicobacter pylori; Eicosanoid; Antipyretic; Bacteriosis; Bacteria; Oxidoreductases; Salicylates; Erosion